CP and cystic fibrosis: We next evaluated the antimicrobial activity of CP against P. aeruginosa strains PA14 and PAO1 under anaerobic and aerobic conditions by treating metal-replete CDM cultures with either 0, 10, or 20 μM CP, concentrations that have been reported in biological and clinical samples including CF patient sputum (79).